Plain-English translation of NCT06319560 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether hydroxychloroquine, a medication traditionally used for malaria and certain autoimmune conditions, can help pregnant women with type 2 diabetes manage their blood sugar more effectively. Half of the participants will take the medication along with their regular diabetes treatment (such as metformin or insulin), while the other half will receive standard care alone. The research team will closely monitor both mother and baby throughout pregnancy and after birth.
Type 2 diabetes during pregnancy can increase risks for both mother and baby, including larger birth weight and complications at delivery. Researchers want to know if this medication might reduce inflammation and help improve blood sugar control when added to standard treatments.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic every 2 to 4 weeks starting at 14–20 weeks of pregnancy. At each visit, your blood sugar will be checked and reviewed, your baby's growth will be monitored by ultrasound, and you'll check your own blood sugar at home seven times a day (before meals and one hour after eating). You'll receive care from a team including an obstetrician, endocrinologist, and diabetes educator. You will have an eye exam before starting the medication. Your baby will be born at 38 weeks or earlier if needed, and you and your child will be seen again at 6 and 12 months after delivery to check the baby's growth and development.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Malaysia